Benzinga's Top Analyst Calls From April 6, 2018

By: via Benzinga
These headlines first appeared on Benzinga Pro. Cantor out defending NewLink Genetics Corp (NASDAQ: NLNK), says indoximod is ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.